Earn more credits by taking our
bundled PCE HOME STUDY activities.
Fall 2021 PCE Symposia Proceedings
- Release Date: March 31, 2022
- Expiration Date: March 30, 2023
Credit Hours Available: 4.00
Pharmacology Hours for NPs: 4.00
- A Focus on Dry Eye Disease: The Role of Primary Care
- Influenza Updates: A Focus on High-Risk Patients
- The Continuum of Care in Psoriatic Disease: Expanding Treatment Options, Individualizing Management
- Expanding Options for Migraine
Podcasts from the GI/GU Oncology Bootcamps Powered by PCE
- Release Date: February 10, 2022
- Expiration Date: February 9, 2023
Credit Hours Available: 5.00
Pharmacology Hours for NPs: 5.00
- HCC: Current State, Available and Emerging Therapies - Episode 1
- HCC: Treatment-Related Adverse Events, Case Discussions and Q&A - Episode 2
- Advanced Urothelial Cancer: Applying New Therapeutic Options - Part 1
- Advanced Urothelial Cancer: Applying New Therapeutic Options - Part 2
- Gastric Cancer: New Strategies, New Therapies, New Hope, Part 1
- Gastric Cancer: New Strategies, New Therapies, New Hope, Part 2
- Making Sense of the Expanding Options in Metastatic Colorectal Cancer Care: Part 1
- Making Sense of the Expanding Options in Metastatic Colorectal Cancer Care: Part 2
- The New Array of Choices in Prostate Cancer—What's Best For Your Patients? Part 1
- The New Array of Choices in Prostate Cancer—What's Best For Your Patients? Part 2
Fall 2021 PCE Oncology
- Release Date: January 31, 2022
- Expiration Date: January 30, 2023
Credit Hours Available: 6.00
Pharmacology Hours for NPs: 6.00
- Addressing the Challenges of Ovarian Cancer
- Evolving Treatment Strategies for CLL/SLL and MCL
- Evolving Role of Immune Checkpoint Inhibitors in NSCLC
- Biomarkers and Molecular Testing of NSCLC: First Step in Choosing Optimal Systemic Therapy
- Applying Novel Advances in R/R Follicular Lymphoma
- CAR-T Cell Therapy Comes of Age in Hematologic Malignancies
2021 PCE Pulmonary Bootcamp
- Release Date: January 28, 2022
- Expiration Date: January 27, 2023
Credit Hours Available: 4.00
Pharmacology Hours for NPs: 4.00
- Asthma Management: Applying Phenotyping and Endotyping to Improve Outcomes in Uncontrolled Asthma
- Targeting COPD: Advanced Management
- Current Topics in Obstructive Sleep Apnea: Treatment of Excessive Daytime Sleepiness
- Bridging the Gap in Pulmonary Arterial Hypertension in Connective Tissue Disease: Promoting Consistent Screening and Management Regimens
2021 PCE Symposia Expert Insights
- Release Date: October 29, 2021
- Expiration Date: October 28, 2022
Credit Hours Available: 7.00
Pharmacology Hours for NPs: 7.00
- Obesity Management Strategies That Can Reap the Benefits of Long-Term Weight Loss
- Individualizing Management of Overactive Bladder
- The Landscape of Inflammatory Bowel Disease
- Hitting Diabetes Head-On: Improving Outcomes and Reducing Therapeutic Inertia With GLP-1 Receptor Agonists
- Multiple Sclerosis in Primary Care
- What’s New in Migraine Management
- Individualizing Management of Uncontrolled Asthma: New Strategies
2021 PCE Symposia Video Lectures
- Release Date: August 31, 2021
- Expiration Date: August 30, 2022
Credit Hours Available: 5.00
Pharmacology Hours for NPs: 5.00
- Reducing the Burden of Uterine Fibroids: Emerging Options for Managing Associated Heavy Menstrual Bleeding
- Critical Strategies and Approaches to Improve Outcomes in Heart Failure
- Clinical Advances in the Treatment of Moderate to Severe Atopic Dermatitis: Optimizing Outcomes
- Managing Influenza in the High-Risk Patient
- Migraine: Putting New Options Into Clinical Practice
Spring 2021 PCE Oncology
- Release Date: August 17, 2021
- Expiration Date: August 16, 2022
Credit Hours Available: 11.00
Pharmacology Hours for NPs: 11.00
- Targeted Therapies in B-Cell Malignancies: Management of Adverse Events in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Mantle Cell Lymphoma
- Expanding the Treatment Landscape for Urothelial Cancer
- Targeting the Clinical Challenges of Metastatic HER2-Positive Breast Cancer With Novel Agents
- Tackling the Complexities of Relapsed/Refractory Follicular Lymphoma: An Update on Recent Advances
- Maximizing the Potential of Novel Therapies for Prostate Cancer
- The Expanding Treatment Landscape for Triple-Negative Breast Cancer
- Changing the Treatment of Endometrial Cancer: Novel and Emerging Strategies
- Navigating the Expanding Options for Relapsed/Refractory Multiple Myeloma
- Optimizing Use of Checkpoint Inhibitors in Non–Small-Cell Lung Cancer
- Biomarkers, Molecular Analysis, and Choice of Therapy in NSCLC
- PARP Inhibitor Therapy for Ovarian Cancer: Recent Advances and Existing Challenges